Citadel Advisors »

Kala Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $106k 14k 7.84

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Kala Pharmaceuticals

Baker Bros. Advisors
Millennium Management
UBS O'Connor
Vanguard Group
BlackRock
Board of Trustees of The Leland Stanford Junior University
Geode Capital Management
Citadel Advisors
Renaissance Technologies
Knights of Columbus Asset Advisors
UBS Group
Tower Research Capital
Morgan Stanley
Covestor
Banque Cantonale Vaudoise

View all funds holding Kala Pharmaceuticals